Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis

BACKGROUND/AIMS: We evaluated the efficacy and safety of daclatasvir (DCV) and asunaprevir (ASV) in patients with chronic hepatitis C virus (HCV) infection on hemodialysis. METHODS: We performed a single-arm, multicenter prospective study. Twenty-one chronic hemodialysis patients with HCV infection...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Gut Liver
Huvudupphovsmän: Lee, Byung Seok, Song, Myeong Jun, Kwon, Jung Hyun, Lee, Tae Hee, Jang, Ji Woong, Kim, Seok Hyun, Lee, Sae Hwan, Kim, Hong Soo, Kim, Ji Hoon, Kim, Seok Bae, Ko, Soon Young, Song, Do Seon
Materialtyp: Artigo
Språk:Inglês
Publicerad: Editorial Office of Gut and Liver 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430432/
https://ncbi.nlm.nih.gov/pubmed/30400729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18240
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk